Iridium 192 implantation of supra-tentorial high grade gliomas recurring in previously irradiated territory: Pitie-Salpetriere Hospital technique, and preliminary results;Curietherapie par iridium 192 des gliomes sus-tentoriels de haut grade recidivant en territoire irradie: Technique du groupe hospitalier Pitie-Salpetriere et resultats preliminaires

Bulletin du Cancer/Radiotherapie

Volumn 83, Issue 3, 1996, Pages 144-152

  Boisserie, G ^a   Cornu, P ^a   Dormont, D ^a   Sahel, M ^a   Hardiman, C ^a   Tep, B ^a   Mandin, A M ^a   Barret, C ^a   Faillot, T ^a   Delattre, J Y ^a   Monjour, A ^b   Poisson, M ^a   Marsault, C ^a   Philippon, J ^a   Simon, J M ^a   Baillet, F ^a   Mazeron, J J ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Pasteur Hospital   (France)

Author keywords

brachytherapy; glioblastoma; iridium 192

Indexed keywords

IRIDIUM 192; IRIDIUM;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; BRAIN TUMOR; CLINICAL ARTICLE; FEMALE; GLIOBLASTOMA; HUMAN; MALE; PRIORITY JOURNAL; STEREOTAXIS; COMPUTER ASSISTED TOMOGRAPHY; GLIOMA; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; MORTALITY; RADIATION DOSE; RADIATION RESPONSE; RADIOGRAPHY; REVIEW; SURVIVAL; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; BRACHYTHERAPY; BRAIN NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GLIOBLASTOMA; GLIOMA; HUMANS; IRIDIUM RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0030331869     PISSN: 09244212     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-4212(96)81746-4     Document Type: Article

References (20)

1. 1 Ammirati M, Galicich JH, Arbit E, Liao Y. Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery 1987;21:607-14
2. 2 Bernstein M, Lapierrere N, Leung P, McKenzie P, Guthrie BL, Selker RG. Interstitial brachytherapy for malignant brain tumors: preliminary results. Neurosurgery 1987;26:371-80
3. 3 Gutin PH, Leibel SA, Wara WM, Choucair A et al. Recurrent maligant gliomas: survival following interstitial brachytherapy with high-activity Iodine-125 sources. J Neurosurg 1987;67:864-73
4. 4 Harsh GR, Levin VA, Gutin PH, Seager M, Silver P, Wilson CB. Reoperation for recurrrent glioblastoma and anaplastic astrocytoma. Neurosurgery 1987;21:615-21
5. 5 Larson GL. Wilbanks JH, Sam Dennis W, Permenter WD, Easley JD. Interstitial radiogold implantation for the treatment of recurrent high-grade gliomas. Cancer 1990;66:27-9
6. 6 Leibel SA, Gutin PH, Wara WM et al. Survival and quality of life after interstitial implantation of removable iodine-125 sources for the treatment of patients with malignant recurrrent gliomas. Int J Radiat Oncol Biol Phys 1989;17:1129-39
7. 7 Loeffler JS, Alexander III E, Hochberg FH et al. Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas. Int J Radiat Oncol Biol Phys 1990;19:1455-62
8. 8 Malkin MG. Interstitial irradiation of malignant gliomas. Rev Neurol 1992;148:448-53
9. 9 Marin LA, Smith CE, Langston MY, Quashie D, Dilleray LE. Response of glioblastoma cell lines to low dose rate irradiation. Int J Radiat Oncol Biol Phys 1991;21:397-402
10. 10 Mundinger F, Weigel K. Long term results of stereotactic interstitial brachytherapy. Acta Neurochir 1984;(Suppl 33):367-71
11. 11 Pasteris C, Benabid AL, De Rougemont J, Vrousos C. Curiethérapie interstitielle des gliomes sus-tentoriels de l'adulte. Bull Cancer Radiother 1992;78:486-7
12. 12 Ostertag CB. Stereotactic interstitial brachytherapy for brain tumors. J Neurosurg Sci 1989;33:83-9
13. 13 Sharfen CO, Sneed PK, Wara WM et al. High activity iodin-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys 1992;24:583-91
14. 14 Shrieve D, Alkexander III E, Wen PY et al. Comparison of stereotactic radiosurgery and brachytherapy in the treatement of recurrent glioblastoma multiforme. Neurosurgery 1995;36:275-84
15. 15 Schupak K, Malkin M, Anderson L, Arbit E, Lindsley K, Leibel S. The relationship between the technical accuracy of stereotactic interstitial implantation for high grade gliomas and the pattern of tumor recurrence. Int J Radiat Oncol Biol Phys 1995;32:1167-76
16. 16 Shapiro WR, Burger PC, Selker RG et al. A randomized trial of interstitial radiotherapy boost for newly diagnosed malignant glioma: Brain Tumor Cooperative Group (BTCG) trial 8701. Proceed Am Soc Clin Oncol 1994;13:174
17. 17 Szikla G, Schlienger M, Blond S et al. Interstitial and combined interstitial and external irradiation of supratentorial gliomas. Results in 61 cases treated 1973-1981. Acta Neurochirurgica 1984;(suppl 33):355-62
18. 18 Szikla G. Central Nervous System. In : B Pierquin, FW Wilson, D Chassagne, eds. Modern Brachytherapy. New York: Masson, 1987;287-99
19. 19 Talairach J, Aboulker J, Ruggiero G, David M. Utilisation de la méthode stéréotaxique pour le traitement radio actif in situ des tumeurs cérébrales. Rev Neurol 1954;90:656-7
20. 20 Wowra B, Schmidt HP, Sturm V. Incidence of late radiation necrosis with transcient mass effect after interstitial low dose rate radiotherapy for cerebral gliomas. Acta Neurochir 1989;99:104-8